Antineoplastic AgentsNeoplasmsRadiation DosageRadiation, IonizingCell Line, TumorRadiation InjuriesDose-Response Relationship, RadiationRadiation ToleranceDrug Screening Assays, AntitumorApoptosisDrug Resistance, NeoplasmRadiationMice, NudeBreast NeoplasmsCell SurvivalRadiation ProtectionXenograft Model Antitumor AssaysDrug Delivery SystemsRadiation MonitoringAntineoplastic Agents, PhytogenicCisplatinDoxorubicinGene Expression Regulation, NeoplasticTreatment OutcomeCell ProliferationColonic NeoplasmsCombined Modality TherapyLung NeoplasmsTumor Cells, CulturedAntibiotics, AntineoplasticProstatic NeoplasmsOvarian NeoplasmsRadiotherapyRadiation OncologyEarly Detection of CancerMolecular Targeted TherapyRetrospective StudiesDNA DamageTime FactorsDrug CarriersNeoplasm MetastasisNeoplasm ProteinsTumor Suppressor Protein p53Cell CycleNeoplasms, Radiation-InducedNeoplasm TransplantationDose-Response Relationship, DrugAntineoplastic Combined Chemotherapy ProtocolsPaclitaxelFollow-Up StudiesGamma RaysPancreatic NeoplasmsRadiation-Sensitizing AgentsStomach NeoplasmsSignal TransductionProspective StudiesClinical Trials as TopicNeoplasm InvasivenessRNA, Small InterferingPostoperative ComplicationsFluorouracilPrognosisCarcinoma, Squamous CellCosmic RadiationBlotting, WesternDrug SynergismCamptothecinSurvival AnalysisRadiotherapy DosageSurvival RateNanoparticlesDrug DesignRadiation Injuries, ExperimentalModels, BiologicalTransplantation, HeterologousEnzyme InhibitorsInhibitory Concentration 50NanomedicineRadiation PneumonitisTumor BurdenEtoposideAdenocarcinomaCarcinomaCell DivisionCancer VaccinesBariatric SurgeryReverse Transcriptase Polymerase Chain ReactionMutationCarcinoma, Non-Small-Cell LungRNA, MessengerNeoplasms, ExperimentalNeoplasm StagingNeovascularization, PathologicDrug Resistance, MultipleNational Cancer Institute (U.S.)Neoplasm Recurrence, LocalAntimetabolites, AntineoplasticDNA RepairTumor Markers, BiologicalColorectal Neoplasms